32
Participants
Start Date
October 31, 2007
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Imprime PGG 2 mg/kg
Infusion of 2mg/kg on Day 1 of each week for 6 weeks (one cycle) Number of Cycles: until progression or unacceptable toxicity develops.
Imprime PGG 4 mg/kg
Infusion of 4mg/kg on Day 1 of each week for 6 weeks (one cycle). Number of Cycles: until progression or unacceptable toxicity develops.
Cetuximab
Infusion 400 mg/m2 over 2 hours on Day 1, then 250 mg/m2 over 1 hour on Days 8, 15, 22, 29, and 36 of each 6-week treatment cycle;
Irinotecan
Infusion 125 mg/m2 i.v. over 1.5 hours on Days 1, 8, 15, and 22 of each 6-week treatment cycle
Imprime PGG 6mg/kg
Infusion of 6mg/kg on Day 1 of each week for 6 weeks (one cycle) Number of Cycles: until progression or unacceptable toxicity develops.
Medical City, Makati City
Philippine General Hospital, Manila
Lead Sponsor
HiberCell, Inc.
INDUSTRY